Study
Medisafe Study: Positive Impact on Adherence in HIV Patients Using Single-tablet Antiretroviral Therapy
MIAMI — June 7, 2018 — Medisafe, the leading medication management platform with almost four and a half million registered users, today released data showing that previously non-adherent HIV patients increase their prescription refills after they start using the company’s mobile app. These results are part of a landmark study conducted by IQVIA, a leading global providerRead more.
Study
Medisafe Study: Demonstrating Double-Digit Impact on Medication Adherence in Hypertension Patients
Medisafe, the leading medication management platform with almost four and a half million registered users, released data today showing that, on average, hypertensive patients increase their prescription refills by almost 10% after they start using the company’s mobile app. This novel study is being conducted by the leading global provider of information, innovative technology solutionsRead more.
Medisafe’s Latest Study: Significant Adherence and Health Impacts
Dr. Danny Sands Chief Medical Officer, Medisafe Today, Medisafe shared preliminary results of a study performed by the leading global provider of information, innovative technology solutions and contract research services focused on healthcare data. The purpose was to understand the real impact of Medisafe on users’ medication adherence. It goes without saying that patients notRead more.
Study
Medisafe Study: Self-Reported Adherence Data Are Consistent with Prescription Refill Claims
Medisafe, the leading medication management platform with over four million registered users, announced today the first wave of results from a novel study, which among other objectives, measures the accuracy of self-reported outcomes (SROs). Medisafe’s study was conducted in partnership with the leading global provider of information, innovative technology solutions and contract research services focusedRead more.
Data
IQVIA Study-The Growing Value of Digital Health
In a recent study conducted by the prominent IQVIA Institute for Human Data Science (previously QuintilesIMS), designated Medisafe as the “Top Free & Publically Available App for Medication Management.” The report, entitled “The Growing Value of Digital Health: Evidence and Impact on Human Health and the Healthcare System,” highlights Medisafe’s leadership position in an industryRead more.
Adherence
Case Study: Medisafe Platform, App Increase Medication Adherence
The following originally appeared in Population Health News July 2017 issue (Volume 4, Issue 7), published by Health Policy Publishing, LLC. Objectives: Evaluate the impact of Medisafe on a cohort of patients with hypertension, hyperlipidemia or Evaluate the uses of digital technology for managing chronic illnesses Program Description: Founded in 2012, Medisafe is a leadingRead more.
Adherence
Inc.: Could AI Be a Game-Changer for SMBs?
Excerpt: Not too long ago, it was the stuff of scary science fiction, but today artificial intelligence–AI–is fast becoming a useful and accessible technology. It’s still in its early stages, so larger organizations with significant IT budgets have been the early adopters. But affordable “pre-trained” generic services that use third-party data and are suitable forRead more.
Data
Medisafe Improves Adherence and Lowers Costs For Chronic Disease Patients
Medisafe collaborated with IMS Health to conduct a study evaluating med adherence among Medisafe users with hypertension, hyperlipidemia and diabetes against a control group.Read more.
Social Support
The Impact of Medisafe’s ‘Medfriend’ caregiver feature on Adherence
Medisafe analyzed 1,617 non-adherent active users two weeks before and two weeks after they added a Medfriend. 71% of users improved medication adherence after adding a Medfriend.Read more.
Data
Tracking Measurements on Medisafe correlated with Improved Blood Pressure
Medisafe app users experienced significant improvements in their blood pressure levels over a 30-day period, with stage 2 hypertensives decreasing their systolic blood pressure by 25.3 mmHg.Read more.
Pharma
Dear Pharma: Why do you want to build your own adherence app?
Excerpt: “Plato was right. Necessity is the mother of invention. In my [Omri’s] case, necessity was a matter of life and death. My father, diabetic and hypertensive for nearly 20 years, didn’t feel well one Friday afternoon and couldn’t remember if he had taken his medications that day. After telling him that I hadn’t seenRead more.
Adherence
Study: Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps
Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 02.12.2016 Study Rationale and Background Medication nonadherence leads to an estimated 125,000 deaths and costs $100 billion annually in the US. There is a vast pool of tools, including medication adherence apps, which are now available to help patients manage their regimens. However, many of these appsRead more.
Data
Study: Navigating the Flooded Adherence App Marketplace: Rating the Quality of Medication Adherence Apps
The University of Arkansas College of Pharmacy conducted an independent review of available medication adherence apps. The results showed Medisafe as being the premier tool available. Read more.
